Document is current
Any future updates will be listed below
-
Authors
El Naqa, Issam https://orcid.org/0000-0001-6023-1132
Karolak, Aleksandra https://orcid.org/0000-0001-8430-7138
Luo, Yi https://orcid.org/0000-0003-2519-5900
Folio, Les
Tarhini, Ahmad A.
Rollison, Dana
Parodi, Katia
- License Information
-
More Information
Article History
Received: 7 April 2023
Revised: 23 August 2023
Accepted: 25 August 2023
First Online: 8 September 2023
Competing interests
: IEN is on the scientific advisory of Endectra, LLC., act as deputy editor for the journal of Medical Physics and receives funding from NIH and DoD. DER is on the Board of Directors for NanoString technologies, Inc. LRF Research agreement: Philips Healthcare (ended Aug 2021). Patents (no royalties since NIH and military owned). Author royalties, Springer. AAT reports contracted research grants with institution from Bristol Myers Squib, Genentech-Roche, Regeneron, Sanofi-Genzyme, Nektar, Clinigen, Merck, Acrotech, Pfizer, Checkmate, OncoSec; personal consultant/advisory board fees from Bristol Myers Squibb, Merck, Easai, Instil Bio Clinigin, Regeneron, Sanofi-Genzyme, Novartis, Partner Therapeutics, Genentech/Roche, BioNTech, Concert AI, AstraZeneca outside the submitted work.
